XML 59 R56.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and License Agreements (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) (USD $)
In Millions, unless otherwise specified
Sep. 26, 2014
Sep. 27, 2013
Aug. 14, 2014
Mar. 19, 2014
Oct. 01, 2012
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]          
Goodwill (non-tax deductible) $ 2,401.9us-gaap_Goodwill $ 532.0us-gaap_Goodwill      
Questcor Pharmaceuticals, Inc.          
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]          
Cash     445.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Inventory     67.9us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Intangible assets     5,601.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Goodwill (non-tax deductible)     1,771.5us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Other assets, current and non-current     273.9mnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Total assets acquired     8,159.5us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Current liabilities     159.8us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Unpaid purchase consideration (current)     128.8mnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnpaidPurchaseConsideration
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Other liabilities (non-current)     183.7us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Deferred tax liabilities, net (non-current)     1,900.7us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Contingent consideration (non-current)     0us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Total liabilities assumed     2,373.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Net assets acquired     5,786.5us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorPharmaceuticalsInc.Member
   
Cadence Pharmaceuticals, Inc.          
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]          
Cash       43.2us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Inventory       21.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Intangible assets       1,300.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Goodwill (non-tax deductible)       318.1us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Other assets, current and non-current       18.0mnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Total assets acquired       1,700.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Current liabilities       60.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Other liabilities (non-current)       18.7us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Deferred tax liabilities, net (non-current)       292.3us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Contingent consideration (non-current)       0us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Total liabilities assumed       371.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
Net assets acquired       1,329.2us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= mnk_CadencePharmaceuticalsInc.Member
 
CNS Therapeutics, Inc.          
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]          
Cash         3.6us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Intangible assets         91.9us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Goodwill (non-tax deductible)         24.5us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Other assets, current and non-current         9.7mnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Total assets acquired         129.7us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Current liabilities         4.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Deferred tax liabilities, net (non-current)         27.1us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Contingent consideration (non-current)         6.9us-gaap_BusinessCombinationContingentConsiderationLiability
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Total liabilities assumed         38.0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember
Net assets acquired         $ 91.7us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= mnk_CnsTherapeuticsIncMember